Embryonic stem cell lines derived from human blastocysts

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

The Truly Staggering Cost of Inventing New Drugs

Vioxx's history and the need for better procedures and better testing

スーザン・ソロモンは幹細胞を「私たちの体の修理キット」と呼び、研究室で育てた幹細胞を用いた研究を提唱します。彼女のチームは多能性幹細胞株(iPS細胞株)を育てることで、疾患の完治に関する研究を促進し得る試験環境を作り上げます。これは将来的には特定の疾患でなく特定の人を対象としたオーダーメード医療につながります。

幹細胞研究の将来

Lab-grown stem cells are transforming disease research and drug development, moving medicine beyond a one-size-fits-all approach. Scientists can now create thousands of genetically diverse stem cell avatars, allowing for 'clinical trials in a dish' using real human cells. This breakthrough could slash the average 13-year, $4 billion cost of bringing a single drug to market. By modeling diseases in human cells, researchers gain an unprecedented window into both illness and potential cures.

Stem Cells Unlock the Future of Truly Personalized Medicine

health care

medical research

science

technology

biology

medicine

biotech

disease

health

innovation

bioethics

illness

genetics

economics

future

medical imaging

drugs

TED Stage Talk

スーザン・ソロモン: 幹細胞研究の将来